RS Medical

RS Medical is a long-established, commercial-stage medical device company focused on non-narcotic pain management and physical rehabilitation. Its core innovation is the RS-4i Plus, a prescription electrotherapy device featuring the patented Intersperse technology, which sequentially and intermixes IFT and NMES to trigger endogenous opioid releases for lasting pain relief. The company operates a B2B2C model, servicing healthcare practitioners and patients, and boasts substantial real-world evidence from over 30,000 patient outcomes. RS Medical positions itself as a service-oriented partner to clinicians in the growing market for non-opioid pain therapies.

Patented Intersperse electrotherapy platform combining Interferential Therapy (IFT) and Neuromuscular Electrical Stimulation (NMES) in a sequenced protocol to trigger endogenous opioid (enkephalin and endorphin) release for pain relief and muscle rehabilitation.

RS Medical competes in the electrotherapy segment against both consumer-grade TENS/EMS device companies (e.g., Omron, Icy Hot) and other prescription-focused medical device firms. Its key differentiation is the patented Intersperse protocol, clinical support services, and its established prescriber network. It also competes broadly with other non-drug pain therapies like physical therapy tools, braces, and pharmacological alternatives.